Dec 06, 2018 - Ultra-thinly traded BeyondSpring (BYSI +3.2%) is up on almost double normal volume, albeit on turnover of only 12K shares, on the heels of its announcement of positive results evaluating lead candidat
Dec 06, 2018 - Results from a Phase 3 clinical trial, RECOVER, evaluating Spectrum Pharmaceuticals' (SPPI -2.4%) ROLONTIS (eflapegrastim) for reducing the duration of severe neutropenia (low levels of a type of whit
Dec 05, 2018 - The 14th edition of the Amgen Tour of California will include a stage running from Ontario to Mt. Baldy and will finish in Pasadena.
Dec 05, 2018 - This week, focus was on data presented at the annual conference of the American Society of Hematology from Dec 1-4. Apart from this, the regular pipeline updates were also in focus in the biotech sector.
Dec 05, 2018 -
The 14th edition of the Amgen Tour of California cycling race will start in Sacramento on May 12 and work its way down to the finish line in Pasadena on May 18, covering more than 750 miles over seven stages.
The course and the dates for the men’s and women’s events were announced by event organizers...
Dec 04, 2018 - The 14th edition of the Amgen Tour of California will include a stage running from Ontario to Mt. Baldy and will finish in Pasadena.
Dec 04, 2018 - Amgen is a relatively new dividend payer, with 8 years of annual dividend increases. But the dividend has room to grow at a high rate moving forward. New products such as Repatha and Prolia will lead
Dec 03, 2018 - AbbVie (ABBV) strikes a deal with Pfizer to launch its biosimilar of Humira in the United States in November
Nov 29, 2018 - Synthorx intends to raise $100 million from the sale of its common stock.The firm is advancing a pipeline of treatment candidates for various cancers and autoimmune diseases.THOR has strong support fr
Nov 29, 2018 - The FDA's Reproductive and Urologic Drugs Advisory Committee will meet on Wednesday, January 16, 2019, to review and discuss Amgen's (AMGN -0.4%) resubmitted marketing application seeking approval fo